Search results - 4 results

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)

study population, older age was associated with a higher risk of not having antibodies in wave 2. Among the fully vaccinated, older people and people with at least one chronic disease were at higher risk ...

Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study

chronic disease (OR a 0.22 (95% CI 0.08–0.62)), having received an mRNA-type vaccine (OR a 5.38 (95% CI 1.72–16.80)), and having received an influenza vaccine in 2020–2021 (OR a 3.79 (95% CI 1.30–11.07)). ...

Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study

among the highest educated. Vaccinated people with at least one chronic disease are less likely to have anti- SARS-CoV-2 antibodies than vaccinated people without chronic disease. This difference is not ...

Population vulnerability to COVID-19 in Europe: a burden of disease analysis

health Vulnerability YLD Abstract: Background Evidence has emerged showing that elderly people and those with pre-existing chronic health conditions may be at higher risk of developing severe health ...

QR code

QR code for this page URL